A single psilocybin dose can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, it demonstrates the potential of psychedelic therapy in the context of cancer.

Source of Article

A landmark clinical trial testing the effect of microdosing LSD on symptoms of ADHD recently delivered its first data readout and the results have been surprising, to say the least, raising questions over the efficacy of this popular trend.

Source of Article